Where does BioMimetic Therapeutics, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), BioMimetic Therapeutics, LLC ranks #19,517 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does BioMimetic Therapeutics, LLC hold?

BioMimetic Therapeutics, LLC holds 14 US utility patents granted between 2015 and 2023, spanning 7 technology areas.

What is BioMimetic Therapeutics, LLC's Innovation Score?

BioMimetic Therapeutics, LLC has an Innovation Score of 38.1 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does BioMimetic Therapeutics, LLC focus on?

BioMimetic Therapeutics, LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 14 patents, ranking #1,384 of 6,058 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is BioMimetic Therapeutics, LLC's patent grant rate increasing or decreasing?

BioMimetic Therapeutics, LLC's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for BioMimetic Therapeutics, LLC's patents?

BioMimetic Therapeutics, LLC's patents average 27.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the BioMimetic Therapeutics, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

BioMimetic Therapeutics, LLC

USPTO PatentsView assignee record - 14 granted patents across 7 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biomimetic ranks #19,517 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 7 technology areas.

#19,517
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.1/100): 27.9
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19517 · US Corporation #19,517 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #19,517/49,997
PHOTO-FINISH Benecke-Kaliko
CPC-NARROW A61P · 7 areas
INNOV-THIN 38.1/100
CLAIMS-DENSE 27.9 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Benecke-Kaliko AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biomimetic’s 38.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (25%) Velocity 4.4 pts (12%) Breadth 9.4 pts (25%) Claim depth 15.0 pts (39%)

Qualcomm Incorporated · highest

85
BioMimetic Therapeut… · this assignee

38
3D Lighting… · lowest

7

What this shows Biomimetic's Innovation Score is 38.1/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biomimetic?

Each dot is one of Biomimetic’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biomimetic’s own 27.9 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biomimetic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biomimetic's grants concentrate

BioMimetic Therapeutics, LLC is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2015. By volume, Biomimetic sits between Benecke-Kaliko AG and BlueTalon, Inc..

Biomimetic's three-year grant acceleration

BioMimetic Therapeutics, LLC shows 4 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Benecke-kaliko

14
Berry Metal

14
Beyond Innovation…

14
Biglobe

14
Biochar Now

14
Bitglass

14
Blended Wing Airc…

14
Bluetalon

14
Biomimetic Therap… ◀

14

What this shows BioMimetic holds 14 patents at rank #19,530, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near BioMimetic

By rank, the assignees closest to #19,530 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in BioMimetic's primary technology class.

Biomimetic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

BioMimetic Therapeutics, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	7.1%
2017	3	21.4%
2019	3	21.4%
2020	1	7.1%
2021	2	14.3%
2022	3	21.4%
2023	1	7.1%

Which technologies does BioMimetic Therapeutics, LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 11

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

C07K - Peptides 5

Y02A - Technologies FOR Adaptation TO Climate Change 3

A61B - DIAGNOSIS; SURGERY; Identification 2

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

BioMimetic Therapeutics, LLC's patent record in context - here's where to go next.

BioMimetic Therapeutics, LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #19,517 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare BioMimetic Therapeutics, LLC against Benecke-Kaliko AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.